Comments on: FDA Commish Serves Some Dish http://www.pharmalot.com/2007/02/fda_commish_serves_some_dish/ News, Comment and Conversation Fri, 10 Feb 2012 18:41:40 +0000 http://wordpress.org/?v=2.6.2 By: ed http://www.pharmalot.com/2007/02/fda_commish_serves_some_dish/#comment-2696 ed Fri, 23 Feb 2007 14:52:34 +0000 http://plt.starledger.webfactional.com/2007/02/fda_commish_serves_some_dish/#comment-2696 Preventing whistleblowing is a diffciult thing. The real issue is the environment that encouarges some people to believe that's the only route for disclosing information. That may require a complete makeover at the agency's higher echelons. For any FDA commish, the challenge is to alter the goals and thinking that made some staffers feel there were no alternatives. Several agency employees took this route - either publicly or by seeking out journalists - over the past few years, going back to the Rezulin controversy. That's a sign of systemic problems. Rather than blame the individuals, an effective leader will examine why so many agency staffers felt compelled to speak out. Whether von Eschenbach actually cares about this remains to be seen, but it takes more than telling employees to get in line for the sake of running a tight ship. Preventing whistleblowing is a diffciult thing. The real issue is the environment that encouarges some people to believe that’s the only route for disclosing information.

That may require a complete makeover at the agency’s higher echelons. For any FDA commish, the challenge is to alter the goals and thinking that made some staffers feel there were no alternatives.

Several agency employees took this route - either publicly or by seeking out journalists - over the past few years, going back to the Rezulin controversy. That’s a sign of systemic problems.

Rather than blame the individuals, an effective leader will examine why so many agency staffers felt compelled to speak out. Whether von Eschenbach actually cares about this remains to be seen, but it takes more than telling employees to get in line for the sake of running a tight ship.

]]> By: Melody http://www.pharmalot.com/2007/02/fda_commish_serves_some_dish/#comment-2695 Melody Wed, 21 Feb 2007 22:07:29 +0000 http://plt.starledger.webfactional.com/2007/02/fda_commish_serves_some_dish/#comment-2695 "To go outside the process is destructive, not constructive....They aren't speaking in the best interest of the FDA....I expect people to adhere to that, because that's the way to do business. When whistleblowers magnanimously decide to act in the best interest of CITIZENS instead of the FDA, they shouldn't be punished. The FDA has a long history of giving economic corporate interests precedence over American citizens well-being. Oh--they'll eventually get around to doing the right thing, but every day they delay--whether it be requiring post-marketing data collection, black box warnings, or market withdrawal--the economic benefit to the manufacturer outstrips the legal liability. These arroganct utterings by von Eschenbach regarding "the average citizen" belies his "transparency" issues. I have seen nothing to change my opinion than this agency remains just whatt other journalists have so aptly labeled it--a LAPDOG for Big Pharma.. “To go outside the process is destructive, not constructive….They aren’t speaking in the best interest of the FDA….I expect people to adhere to that, because that’s the way to do business.

When whistleblowers magnanimously decide to act in the best interest of CITIZENS instead of the FDA, they shouldn’t be punished. The FDA has a long history of giving economic corporate interests precedence over American citizens well-being. Oh–they’ll eventually get around to doing the right thing, but every day they delay–whether it be requiring post-marketing data collection, black box warnings, or market withdrawal–the economic benefit to the manufacturer outstrips the legal liability.

These arroganct utterings by von Eschenbach regarding “the average citizen” belies his “transparency” issues. I have seen nothing to change my opinion than this agency remains just whatt other journalists have so aptly labeled it–a LAPDOG for Big Pharma..

]]>